Combination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This phase II clinical trial studies how well combining different regimens of chemotherapy
and gefitinib with radiation therapy work in treating patients with stage III non-small cell
lung cancer. Drugs used in chemotherapy work in different ways to stop the growth of tumor
cells, either by killing the cells or by stopping them from dividing. Biological therapies
such as gefitinib may interfere with the growth of tumor cells and slow the growth of
non-small cell lung cancer. Radiation therapy uses high-energy x-rays to damage tumor cells.
Giving different regimens of combination therapy together with gefitinib and radiation
therapy may be an effective treatment for non-small cell lung cancer.